Cardiac tissue engineering stands at the forefront of innovative medical research, representing a convergence of medicine, biology, and engineering. This cutting-edge field is driven by the urgent need to address the complexities of heart diseases and the limitations in organ transplantation. Researchers are pioneering novel strategies to overcome the scarcity of donor organs by leveraging biomaterials, stem cells, and advanced fabrication techniques. Through the meticulous construction of three-dimensional structures that closely emulate the heart's intricate architecture, scientists aim to create functional cardiac tissues in a laboratory setting. The overarching objective is to produce viable tissue replacements capable of seamlessly integrating into a patient's heart, fostering regeneration and restoring optimal cardiac function. This transformative approach holds immense promise in reshaping the landscape of cardiovascular disorder treatments, offering tailored solutions and diminishing reliance on conventional transplantation methods. Despite existing challenges, such as achieving electrical integration and vascularization, cardiac tissue engineering stands as a beacon of hope in advancing more effective therapies for heart-related conditions.
Title : Investigating the long-term follow up of atrial septal device closures in wales and england: A comparative analysis with major adverse cardiovascular Events (MACE)
Meera Gopinath, Cardiff University Medical school, United Kingdom
Title : An adult case of polysplenia syndrome associated with sinus node dysfunction
Apoorva Tripathi, Oxford University Hospitals, United Kingdom
Title : A unique cell-driven phenomenon in the heart and the promising future of the innovative translational tools to manage cardiac self-renewal and regeneration
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Personalized and precision medicine (PPM) as a unique healthcare model through biodesign-driven translational applications and cardiology-related healthcare marketing to secure the human healthcare and biosafety
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Yasser’s criterion of inferior ST-segment discrepancy deviations in AF with aberrancy and Sgarbosa criteria - a new cardiovascular discovery and management - a case report
Yasser Mohammed Hassanain Elsayed, Egyptian Ministry of Health, Egypt